Invention Grant
- Patent Title: Heterocyclic compound
-
Application No.: US17296434Application Date: 2019-11-27
-
Publication No.: US12152027B2Publication Date: 2024-11-26
- Inventor: Takaharu Hirayama , Yoshiteru Ito , Noriyuki Nii , Youichi Kawakita , Shinichi Imamura
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Sughrue Mion, PLLC
- Priority: JP2018-222530 20181128
- International Application: PCT/JP2019/046261 WO 20191127
- International Announcement: WO2020/111087 WO 20200604
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D471/04

Abstract:
Provided is a compound that can have an effect of inhibiting MALT1 and is expected as useful as a prophylactic or therapeutic drug for cancer, etc. A compound represented by formula (I) [wherein each symbol is as defined in the description], a salt thereof, or a cocrystal, a hydrate or a solvate of the same.
Information query